GARDASIL®9 is the first and only vaccine that helps protect individuals aged 9–45 against 9 human papillomavirus (HPV) types that can cause certain cancers & diseases.
Connect with a healthcare professional today to discuss HPV vaccination and find a vaccination site near you. You can also follow our step-by-step guide on how to get GARDASIL®9.
About 75% of sexually active Canadians will have at least one HPV infection during their lifetime. Many people who have HPV don’t even realize it because the virus often has no signs or symptoms – which means they can pass on the virus to others without knowing it.
All eligible individuals aged 9 through 45 should consider getting GARDASIL®9 to help protect themselves against genital warts and certain HPV-related cancers.
HPV causes nearly 100% of cervical cancer cases as well as other cancers & diseases.Learn more
Vaccinating your child now can help protect them against certain HPV-related cancers & diseases in the future.Learn more
Public coverage for GARDASIL®9 is available and varies by province or territory, and by age or risk factors.
You may have private health insurance through work or school. Many private insurance plans reimburse some or all of the cost of GARDASIL®9.
FACT: HPV doesn’t discriminate between the sexes. Men and women who are sexually active are equally at risk of getting an HPV infection.Learn more
FACT: Being in a monogamous relationship does NOT protect you from HPV infections.Learn more
FACT: HPV is the most common sexually transmitted infection in the world. It is estimated that 75% of sexually active Canadians will have at least one HPV infection in their lifetime.Learn more
FACT: Condoms may not be enough to protect you against HPV – they only protect the area they cover.Learn more
Even if you think you’re too young, you could still be at risk. This is Christa’s C-story.
Diagnosed with cervical cancer at age 33.
“On the day I gave birth to my son, I was diagnosed with cervical cancer. Nothing could have been more of a shock to me. I struggled to share the news of my diagnosis with loved ones because I didn’t want this serious news to take away from the very exciting news that I had given birth to a beautiful baby boy.”
Christa was an incredible mother. Although she sadly did not survive her battle with cancer, she was a fighter and was open and honest about her illness.
In girls and women aged 9 through 45, GARDASIL®9 helps protect against cervical, vaginal, vulvar and anal cancers caused by HPV types 16, 18, 31, 33, 45, 52, and 58, abnormal and precancerous cervical lesions as found in a Pap test caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, abnormal and precancerous vaginal, vulvar and anal lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, and genital warts caused by HPV types 6 and 11. In boys and men aged 9 through 45, GARDASIL®9 helps protect against anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58, and abnormal and precancerous anal lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. It also helps protect boys and men aged 9 through 45 against genital warts caused by HPV types 6 and 11.
GARDASIL®9 does not treat HPV infection, cancer or prevent its complications. GARDASIL®9 may not fully protect each person who gets it. GARDASIL®9 does not remove the need for cervical cancer screening; women should still get routine cervical cancer screening. GARDASIL®9 is not recommended for use in pregnant women. As with other vaccines, GARDASIL®9 may cause some side effects and allergic reactions. The most common side effects seen are pain, swelling, redness, itching, bruising, bleeding, a lump where the shot is given, headache, fever, nausea, dizziness, tiredness, diarrhea, abdominal pain and sore throat. This is not a complete list of side effects; for any unexpected effects while
taking GARDASIL®9, contact your doctor or pharmacist. Contact your doctor or healthcare professional to if GARDASIL®9 is suitable for you.
Information about GARDASIL®9 is provided in the Product Monograph and Consumer Information, available here.